BioRestorative Therapies Inc (BRTX) stock news · rev $359.7K
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
This BRTX news page leads with what BioRestorative Therapies Inc filed — not a scraped headline mill.
No cached 8-K sentence for BRTX yet. We will not pad this page with generic market recap.
Latest reported BRTX revenue for 2025-12-31 was $359.7K. Net income was -$14.2M. Revenue was down 10.3% from 2024-12-31 to 2025-12-31. BRTX currently screens at market cap $10.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BRTX stock page; for the tape open the quote page.
BRTX stock news FAQ
What are BRTX's latest revenue and net income?
Latest cached BioRestorative Therapies Inc (BRTX) revenue for Dec 31, 2025 was $359.7K. Net income was -$14.2M. Statements: https://lician.com/financials/brtx
How did BRTX revenue change from the prior cached period?
Cached BioRestorative Therapies Inc (BRTX) revenue was down 10.3% from $401.0K (Dec 31, 2024) to $359.7K (Dec 31, 2025). Statements: https://lician.com/financials/brtx
What is BRTX's market cap?
BioRestorative Therapies Inc (BRTX) market cap is $10.2M on the latest cached fundamentals snapshot.
What kind of company is BRTX?
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Where is BRTX stock news listed?
Cached stock news for BioRestorative Therapies Inc (BRTX) is listed at https://lician.com/news/brtx. Filings: https://lician.com/sec/brtx
Not investment advice.